Aguilar MC, Gurpegui M, Diaz FJ, de Leon J (2005). Nicotine dependence and symptoms in schizophrenia: naturalistic study of complex interactions. British Journal of Psychiatry 186, 215–221.
Barr RS, Culhane MA, Jubelt LE, Mufti RS, Dyer MA, Weiss AP, Deckersbach T, Kelly JF, Freudenreich O, Goff DC, Evins AE (2008). The effects of transdermal nicotine on cognition in nonsmokers with schizophrenia and nonpsychiatric controls. Neuropsychopharmacology 33, 480–490.
Dalack GW, Healy DJ, Meador-Woodruff JH (1998). Nicotine dependence in schizophrenia: clinical phenomena and laboratory findings. American Journal of Psychiatry 155, 1490–1501.
de Leon J, Diaz FJ (2005). A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophrenia Research 76, 135–157.
de Leon J, Diaz FJ (2012). Genetics of schizophrenia and smoking: an approach to studying their comorbidity based on epidemiological findings. Human Genetics 131, 877–901.
de Leon J, Gurpegui M, Diaz FJ (2007). Epidemiology of comorbid tobacco use and schizophrenia: thinking about risks and protective factors. Journal of Dual Diagnosis 3, 9–25.
Dickerson F, Stallings C, Vaughan C, Origoni A, Khushalani S, Dickinson D, Medoff D (2011). Cognitive functioning in recent onset psychosis. Journal of Nervous and Mental Disease 199, 367–371.
Evins AE, Deckersbach T, Cather C, Freudenreich O, Culhane MA, Henderson DC, Green MF, Schoenfeld DA, Rigotti NA, Goff DC (2005). Independent effects of tobacco abstinence and bupropion on cognitive function in schizophrenia. Journal of Clinical Psychiatry 66, 1184–1190.
Fagerström KO (1978). Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addictive Behaviors 3, 235–241.
First MB, Spitzer RL, Gibbon M, Williams JBW (2002). Structured Clinical Interview for DSM-IV-TR Axis I Disorders. Biometrics Research Department, New York State Psychiatric Institute: New York.
Forchuk C, Norman R, Malla A, Martin ML, McLean T, Cheng S, Diaz K, McIntosh E, Rickwood A, Vos S, Gibney (2002). C.Schizophrenia and the motivation for smoking. Perspectives in Psychiatric Care 38, 41–49.
Freedman R, Olincy A, Ross RG, Waldo MC, Stevens KE, Adler LE, Leonard S (2003). The genetics of sensory gating deficits in schizophrenia. Current Psychiatry Reports 5, 155–161.
George TP, Vessicchio JC, Termine A, Sahady DM, Head CA, Pepper WT, Kosten TR, Wexler BE (2002). Effects of smoking abstinence on visuospatial working memory function in schizophrenia. Neuropsychopharmacology 26, 75–85.
Goff DC, Henderson DC, Amico E (1992). Cigarette smoking in schizophrenia: relationship to psychopathology and medication side effects. American Journal of Psychiatry 149, 1189–1194.
Gu D, Kelly TN, Wu X, Chen J, Samet JM, Huang JF, Zhu M, Chen JC, Chen CS, Duan X, Klag MJ, He J (2009). Mortality attributable to smoking in China. New England Journal of Medicine 360, 150–159.
Harris JG, Kongs S, Allensworth D, Martin L, Tregellas J, Sullivan B, Zerbe G, Freedman R (2004). Effects of nicotine on cognitive deficits in schizophrenia. Neuropsychopharmacology 29, 1378–1385.
Kay SR, Fiszbein A, Opler LA (1987). The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin 13, 261–276.
Kelly C, McCreadie RG (1999). Smoking habits, current symptoms, and premorbid characteristics of schizophrenic patients in Nithsdale, Scotland. American Journal of Psychiatry 156, 751–757.
Kelly DL, McMahon RP, Wehring HJ, Liu F, Mackowick KM, Boggs DL, Warren KR, Feldman S, Shim JC, Love RC, Dixon L (2011). Cigarette smoking and mortality risk in people with schizophrenia. Schizophrenia Bulletin 37, 832–838.
Kumari V, Postma P (2005). Nicotine use in schizophrenia: the self medication hypotheses. Neuroscience and Biobehavioral Reviews 29, 1021–1034.
Lee S, Guo WJ, Tsang A, Huang YQ, He YL, Kessler RC (2009). Prevalence and correlates of active and ever-smokers in metropolitan China. Addictive Behaviors 34, 969–972.
Leonard S, Gault J, Hopkins J, Logel J, Vianzon R, Short M, Drebing C, Berger R, Venn D, Sirota P, Zerbe G, Olincy A, Ross RG, Adler LE, Freedman R (2002). Association of promoter variants in the alpha7 nicotinic acetylcholine receptor subunit gene with an inhibitory deficit found in schizophrenia. Archives of General Psychiatry 59, 1085–1096.
Leonard S, Mexal S, Freedman R (2007). Smoking, genetics and schizophrenia: evidence for self medication. Journal of Dual Diagnosis 3, 43–59.
Lieberman JA, Javitch JA, Moore H (2008). Cholinergic agonists as novel treatments for schizophrenia: the promise of rational drug development for psychiatry. American Journal of Psychiatry 165, 931–936.
Lyons MJ, Bar JL, Kremen WS, Toomey R, Eisen SA, Goldberg J, Faraone SV, Tsuang M (2002). Nicotine and familial vulnerability to schizophrenia: a discordant twin study. Journal of Abnormal Psychology 111, 687–693.
Ma X, Li C, Meng H, Du L, Wang Q, Wang Y, Deng W, Liu X, Hu X, Murray RM, Collier DA, Li T (2010). Premorbid tobacco smoking is associated with later age at onset in schizophrenia. Psychiatry Research 178, 461–466.
Martin LF, Freedman R (2007). Schizophrenia and the alpha7 nicotinic acetylcholine receptor. International Review of Neurobiology 78, 225–246.
McEvoy JP, Brown S (1999). Smoking in first-episode patients with schizophrenia. American Journal of Psychiatry 156, 1120–1121.
Mobascher A, Winterer G (2008). The molecular and cellular neurobiology of nicotine abuse in schizophrenia. Pharmacopsychiatry 41 (Suppl. 1), S51–S59.
Moncrieff J (2009). A critique of the dopamine hypothesis of schizophrenia and psychosis. Harvard Review of Psychiatry 17, 214–225.
Montgomery AJ, Lingford-Hughes AR, Egerton A, Nutt DJ, Grasby PM (2007). The effect of nicotine on striatal dopamine release in man: a [11C]raclopride PET study. Synapse 61, 637–645.
Myles N, Newall HD, Curtis J, Nielssen O, Shiers D, Large M (2012). Tobacco use before, at, and after first-episode psychosis: a systematic meta-analysis. Journal of Clinical Psychiatry 73, 468–475.
Olincy A, Braff DL, Adler LE, Cadenhead KS, Calkins ME, Dobie DJ, Green MF, Greenwood TA, Gur RE, Gur RC, Light GA, Mintz J, Nuechterlein KH, Radant AD, Schork NJ, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Wagner BD, Freedman R (2010). Inhibition of the P50 cerebral evoked response to repeated auditory stimuli: results from the Consortium on Genetics of Schizophrenia. Schizophrenia Research 119, 175–182.
Olincy A, Harris JG, Johnson LL, Pender V, Kongs S, Allensworth D, Ellis J, Zerbe GO, Leonard S, Stevens KE, Stevens JO, Martin L, Adler LE, Soti F, Kem WR, Freedman R (2006). Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia. Archives of General Psychiatry 63, 630–638.
Olincy A, Young DA, Freedman R (1997). Increased levels of the nicotine metabolite cotinine in schizophrenic smokers compared to other smokers. Biological Psychiatry 42, 1–5.
Phillips MR, Shen Q, Liu X, Pritzker S, Streiner D, Conner K, Yang G (2007). Assessing depressive symptoms in persons who die of suicide in mainland China. Journal of Affective Disorders 98, 73–82.
Randolph C, Tierney MC, Mohr E, Chase TN (1998). The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity. Journal of Clinical and Experimental Neuropsychology 20, 310–319.
Sacco KA, Termine A, Seyal A, Dudas MM, Vessicchio JC, Krishnan-Sarin S, Jatlow PI, Wexler BE, George TP (2005). Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms. Archives of General Psychiatry 62, 649–659.
Samele C, Patel M, Boydell J, Leese M, Wessely S, Murray R (2007). Physical illness and lifestyle risk factors in people with their first presentation of psychosis. Social Psychiatry and Psychiatric Epidemiology 42, 117–124.
Scottish Schizophrenia Research Group (2000). Smoking habits and plasma lipid peroxide and vitamin E levels in never-treated first-episode patients with schizophrenia. British Journal of Psychiatry 176, 290–293.
Smith RC, Infante M, Ali A, Nigam S, Kotsaftis A (2001). Effects of cigarette smoking on psychopathology scores in patients with schizophrenia: an experimental study. Substance Abuse 22, 175–186.
Smith RC, Warner-Cohen J, Matute M, Butler E, Kelly E, Vaidhyanathaswamy S, Khan A (2006). Effects of nicotine nasal spray on cognitive function in schizophrenia. Neuropsychopharmacology 31, 637–643.
Strand JE, Nybäck H (2005). Tobacco use in schizophrenia: a study of cotinine concentrations in the saliva of patients and controls. European Psychiatry 20, 50–54.
Weiser M, Reichenberg A, Grotto I, Yasvitzky R, Rabinowitz J, Lubin G, Nahon D, Knobler HY, Davidson M (2004). Higher rates of cigarette smoking in male adolescents before the onset of schizophrenia: a historical prospective cohort study. American Journal of Psychiatry 161, 1219–1223.
Wing VC, Bacher I, Sacco KA, George TP (2011). Neuropsychological performance in patients with schizophrenia and controls as a function of cigarette smoking status. Psychiatry Research 188, 320–326.
Winterer G (2010). Why do patients with schizophrenia smoke? Current Opinion in Psychiatry 23, 112–119.
Zanelli J, Reichenberg A, Morgan K, Fearon P, Kravariti E, Dazzan P, Morgan C, Zanelli C, Demjaha A, Jones PB, Doody GA, Kapur S, Murray RM (2010). Specific and generalized neuropsychological deficits: a comparison of patients with various first-episode psychosis presentations. American Journal of Psychiatry 167, 78–85.
Zhang BH, Tan YL, Zhang WF, Wang ZR, Yang GG, Shi C, Zhang XY, Zhou DF (2009). Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) as a screening test in Chinese: reliability and validity. Chinese Mental Health Journal 28, 865–869.
Zhang XY, Li CB, Li M, Zheng YL, Zhang CX, Yan QZ, Liu WZ, Kang YM, Wang F, Chen DC, Xiu MH, Kosten TR (2010). Smoking initiation and schizophrenia: a replication study in a Chinese Han population. Schizophrenia Research 119, 110–114.
Zhang XY, Liang J, Chen DC, Xiu MH, He J, Cheng W, Wu Z, Yang FD, Haile CN, Sun H, Lu L, Kosten TA, Kosten TR (2012). Cigarette smoking in male patients with chronic schizophrenia in a Chinese population: prevalence and relationship to clinical phenotypes. PLoS ONE 7, e30937.
Ziedonis D, Williams JM, Smelson D (2003). Serious mental illness and tobacco addiction: a model program to address this common but neglected issue. American Journal of the Medical Sciences 326, 223–230.
Ziedonis DM, Kosten TR, Glazer WM, Frances RJ (1994). Nicotine dependence and schizophrenia. Hospital and Community Psychiatry 45, 204–206.